Episode 1: The End of Wet Labs? How Digital is Virtualizing Pharma Research
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Episode 1: The End of Wet Labs? How Digital is Virtualizing Pharma Research
-
Narrado por:
-
De:
Acerca de esta escucha
In this episode, we tackle a transformative question: will traditional wet labs be rendered obsolete by digital and AI-powered innovations? Host Nicola Hill is joined by Professor Russ Altman from Stanford University, and Dr. Alistair Henry, UCB’s Chief Scientific Officer, to debate the rise of virtual pharmaceutical research.
Discover how technologies like machine learning, in silico compound screening, and digital twins are redefining drug discovery. From unprecedented advancements to persistent challenges, our experts dissect whether digital simulations can truly replicate—and surpass—the capabilities of physical labs. Will a hybrid model of digital and traditional methods shape the future of pharma research?
This podcast is produced and funded by UCB.
Hosted on Acast. See acast.com/privacy for more information.
Hosted on Acast. See acast.com/privacy for more information.